vimarsana.com

Latest Breaking News On - Xenon pharmaceuticals inc - Page 1 : vimarsana.com

Avoro Capital Advisors LLC Has $261 01 Million Stake in Xenon Pharmaceuticals Inc (NASDAQ:XENE)

Avoro Capital Advisors LLC grew its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 15.6% during the 4th quarter, HoldingsChannel reports. The firm owned 5,666,666 shares of the biopharmaceutical company’s stock after acquiring an additional 766,666 shares during the quarter. Xenon Pharmaceuticals comprises about 3.6% of Avoro Capital Advisors LLC’s investment portfolio, making […]

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

05.06.2024 - VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global .

Hedge Funds are Racking Up Shares of This Healthcare Stock

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we will look at whether hedge funds like Xenon Pharmaceuticals Inc. (NASDAQ:XENE). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.